Personalized (177)Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial - Del Prete, M; Buteau, FA; Arsenault, F (Eur J Nucl Med Mol Imaging, 2019)
et al.